1. Abad-Esteve A, Diaz-Rubio E, Jimeno JM, Rosell R, Villar A, Gonzalez-Larriba JL (1989) Oral idarubicin in measurable gastric cancer. Am J Clin Oncol — Cancer Clin Trials 12: 14–16
2. Alberteo P, Aapro MS, Iten PA (1990) Phase-II trial of an oral three-drug combination (prednimustine + idarubicin + doxifluridine) in advanced breast cancer. Ann Oncol 1
3. Alberts AS, Falkson G, Rapoport BL, Uys A (1990) A phase-II study of idarubicin and prednisone in multiple myeloma. Tumori 76: 465–466
4. Alvarez A, Brosio C, Albea C, Caruguti A (1989) Phase-II trial with 4-demethoxydaunorubicin (4-dmDNR) in advanced breast cancer. Proc Ann Soc Clin Oncol, San Francisco, 8, abstract 127
5. Ames MM, Reid JM, Feig SA, Gerber MC, Kuffel MJ, Wick MJ (1992) Recent clinical pharmacology and biochemical studies of idarubicin. 24th Congress of the International Society of Haematology, South Bank Centre, London, UK, abstract 591